GLP-1 agonists address the specific appetite and metabolic dysregulation that occurs during menopause by restoring satiety signals and improving insulin sensitivity
Thicker solutions benefit from slightly slower injection speeds and warmer temperatures
Employees using these medications may benefit from nutrition guidance and working with a Registered Dietitian, adequate protein intake, and strength training support (Reference)
To answer this paradigm shift, solutions include: Portfolio modification , notably through acquisitions of health-focused brands (such as Pepsicos acquisitions of Siete Foods and Poppi earlier this year) GLP-1 companions : development of products aimed at reducing the after effects of the drug through muscle preservation, gut-health and also at providing a natural booster effect to the drug
In November 2025, after a pause of more than five years, the FDA approved a reformulated version of H2 blocker ranitidine that addresses the shelf-life deficiencies and impurities present in the previous versions
What GLP-1 Medications Actually Do GLP-1 glucagon-like peptide-1 is a hormone your gut already makes
